Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/08/2000CN1058258C 2-[N-substituted amine alkyl]-5-(E)-alkylmethylene or phenylmethylene cyclopentanone derivatives and application
11/08/2000CN1058176C Compounded Chuanling Dingchuan capsule for asthma
11/08/2000CN1058168C Medicine for curing stomach disease and preparing method thereof
11/08/2000CN1058166C Drug for curing leukopenia and radiation damage
11/08/2000CN1058157C Stomach medicine composition
11/08/2000CN1058155C Medicinal liquid for curing bromhidrosis
11/08/2000CN1058153C Compound metronidazole suppository
11/08/2000CN1058152C Henbane drug give-up agent and its preparation and use
11/08/2000CN1058151C Medicine for curing burn and scald
11/08/2000CN1058150C Topical aromatic releasing compositions
11/07/2000US6143910 Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
11/07/2000US6143907 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/07/2000US6143906 Ascorbyl sorbates
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143883 Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
11/07/2000US6143870 Thrombin receptor homolog
11/07/2000US6143864 Peptides
11/07/2000US6143797 Use of sodium 2-mercaptoethanesulfonate in surgery
11/07/2000US6143796 Method for reducing development of free radical induced malignancies
11/07/2000US6143795 Stable mitoxantrone solutions
11/07/2000US6143794 Topical formulations for the treatment of nail fungal diseases
11/07/2000US6143793 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
11/07/2000US6143792 Treatment of sleep apnea syndrome
11/07/2000US6143791 Therapeutic guanidines
11/07/2000US6143790 Enzyme inhibitors
11/07/2000US6143789 Enantiomorphs
11/07/2000US6143787 Heterocyclic or aromatic oxoacids
11/07/2000US6143785 Inflammatory bowel disease with alkanoyl carnitine in solution
11/07/2000US6143784 Reducing muscle fatigue
11/07/2000US6143783 Amino acids
11/07/2000US6143782 Anti-inflammatory and anti-asthma treatment with reduced side effects
11/07/2000US6143780 Compounds for treatment of aids containing furan or thiophene groups
11/07/2000US6143779 Benzofuranone derivatives and a method for producing them
11/07/2000US6143778 Composition with buffers and nonionic surfactants
11/07/2000US6143777 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143774 Imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
11/07/2000US6143772 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use
11/07/2000US6143761 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy
11/07/2000US6143759 Tetrazoles
11/07/2000US6143757 Chemical compounds
11/07/2000US6143756 Administering manzamine alkaloid
11/07/2000US6143755 Pharmaceutical methods of treatment with ACAT inhibitors and HMG-CoA reductase inhibitors
11/07/2000US6143754 Contraceptives for ovulation inhibition for birth control
11/07/2000US6143753 Pharmaceutical composition for the treatment of malignant neoplasms and immunosuppressive deficiencies and its method of production
11/07/2000US6143752 Hypothyroid conditions by administering propylthiourea
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143748 Multistage process with deetherification and reaction with nitrogen
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000US6143742 Treatment for necrotizing infections
11/07/2000US6143741 Treating or preventing illnesses resulting from damaged endothelial cells such as atherosclerosis, thrombosis, restenosis, vessel spasm by administering hydroxylamine derivative
11/07/2000US6143740 Administering hergulin compound to inhibit cancer cell growth in mammals
11/07/2000US6143738 Therapeutic uses for an aminosterol compound
11/07/2000US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
11/07/2000US6143735 Enhancing blood circulation promoter, comprising combining in oral administration unit does form effective amount of vitamin e and carrier or adjuvant, wherein blood circulation promoter is an ester of salicylic acid
11/07/2000US6143733 Drugs for central nervous system diseases such as parkinson's disease, alzheimer's disease, huntington chorea, amyotrophic lateral sclerosis and olivopontocerebellar degeneration, psychiatric diseases such as anxiety conditions, migraine
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143729 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143726 For treating mycotic infections
11/07/2000US6143725 For treating vascular diseases
11/07/2000US6143724 Used for treatment, improvement and prevention of inflammation and diseases accompanying inflamation
11/07/2000US6143715 For treating and prevention of hepatitis c viurs infections
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143490 In vitro method for deactivation of viral, bacterial, or protozoan pathogen by adding compound consisting of intercalator nucleic acid binding ligand and an attached mustard group, treating the mixture, and recovering blood
11/07/2000US6143329 Aqueous-based pharmaceutical composition
11/07/2000US6143328 Sustained release compositions and a method of preparing pharmaceutical compositions
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143325 Ph modulation; sustained release
11/07/2000US6143323 Containing n-(4-isopropylcyclohexanecarbonyl)phenylalanine inhydroxypropyl cellulose
11/07/2000US6143322 Method of treating humans with opioid formulations having extended controlled release
11/07/2000US6143319 Transdermal therapeutic system containing estradiol
11/07/2000US6143314 Thermoplastic resin
11/07/2000US6143309 Mixture with aprotic solvent; cosmetic
11/07/2000US6143307 Mixture of fatty ester, fatty alcohol and water
11/07/2000US6143302 Headache and colic relief composition with asafetida and method of use thereof
11/07/2000US6143301 In combination with cyclooxygenase inhibitor; dietetics
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000US6143292 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/07/2000US6143287 Applying a mixture of liposome and phthalocyanine; applying light source
11/07/2000US6143279 Uridine 5'-diphosphate and analogs useful for treating lung diseases
11/07/2000US6143278 Topical administration of opioid analgesic agent in admixture with skin or mucosal specific penetration enhancer to produce localized analgesic effect in skin or mucosal tissue without transdermal migration of opiod agent
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6143161 Process for the preparation of 4-(des-dimethylamino)-tetracyclines
11/07/2000CA2179306C Dopamine receptor ligands
11/07/2000CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA2118102C New derivatives of 1,2,3,4-tetrahydronaphthalene, preparation process thereof and pharmaceutical compositions containing the same
11/07/2000CA2083913C Piperazinyl-and piperidinyl-cyclohexanols
11/07/2000CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors
11/07/2000CA2022488C 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
1 ... 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 ... 7860